ArticleThe Journal of antimicrobial chemotherapy2016

A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges.

Martina Kovarova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.